Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou city, Southern China

Table 5 Patients’ characteristics associated with inpatient costs (baseline period)

	Overall		UEBMI		URBMI		P-value
	Mean	SD	Mean	SD	Mean	SD
No. patients	n = 2971		n = 1760		n = 1211
Baseline (2010.11.01–2011.10.31)
Gender							< 0.001
Female	38,472.3	23,410.4	38,225.7	24,643.4	38,890.5	21,176.9
Male	43,930.2	22,323.1	45,357.4	23,775.3	42,049.3	20,111.6
Age group							< 0.001
18 ≤ age < 30	25,980.9	19,092.7	23,158.9	20,005.9	27,520.1	18,478.7
30 ≤ age < 40	31,455.8	22,309.1	28,033.2	24,000.3	34,181.0	20,517.0
40 ≤ age < 50	38,191.0	22,310.9	36,502.7	24,097.8	40,059.8	20,013.3
50 ≤ age < 60	46,378.2	22,167.3	46,652.1	23,057.3	45,724.8	19,910.5
≥ 60	50,470.3	20,403.9	50,308.8	21,999.6	50,812.8	16,559.9
Hospital levels							< 0.001
Primary	18,457.3	15,537.7	15,274.6	13,706.2	23,077.3	17,052.0
Secondary	31,244.4	17,065.9	31,131.6	17,767.6	31,394.8	16,104.8
Tertiary	47,463.3	23,208.1	48,245.2	24,789.2	46,280.6	20,545.9
Length of stay (days)							< 0.001
Days ≤ 100	10,904.7	7104.7	11,444.1	7441.7	9885.3	6308.5
100 < days ≤ 300	33,705.9	14,388.3	35,683.3	15,101.7	30,357.1	12,429.8
> 300 days	57,246.1	12,447.2	60,045.6	13,379.9	53,745.0	10,144.6
Composition of inpatient costs							< 0.001
Laboratory and diagnostic costs	5604.5	7064.7	7447.3	7778.2	2926.2	4736.8
Non-medication treatment costs	24,807.5	14,636.9	23,655.7	14,566.6	26,481.5	14,583.1
Medication costs	4552.4	3483.3	4655.6	3665.6	4402.4	3195.3
Bed fees	6816.5	3597.7	6616.5	3711.5	7107.2	3406.2

P-values are based on the Kruskal–Wallis test. All costs were based on a constant 2014 Chinese Yuan (CNY)
UEBMI Urban Employee Basic Medical Insurance scheme, URBMI Urban Resident Basic Medical Insurance scheme, SD standard deviation

ISSN: 1752-4458